Illumina Reports Financial Results for First Quarter of Fiscal Year 2024

Core Illumina revenue of $1.06 billion for Q1 2024, down 2% from Q1 2023 (down 2% on a constant currency basis) Core Illumina GAAP operating margin of 11.0% and non-GAAP operating margin of 20.6% for Q1 2024 Reiterating fiscal year 2024 Core Illumina revenue guidance that is approximately…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks